Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone
NCT ID: NCT03639857
Last Updated: 2021-07-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2018-08-17
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa
NCT00367328
A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris
NCT02647528
Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
NCT01529996
Comparison of the Efficacy and Safety of Delicate Pulsed Light and Q-Switched 1064 nm Nd:YAG Laser in the Treatment of Post-Acne Erythema
NCT06998589
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea
NCT02268474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
532nm laser and topical corticosteroid
532nm laser is applied to the patient's lesion in-clinic in addition to a topical corticosteroid.
532nm laser
532nm laser will be used to treat the lesion in this study arm.
Topical corticosteroid
The topical corticosteroid will be used to treat the lesion in this study arm.
1064nm laser and topical corticosteroid
1064nm laser is applied to the patient's lesion in-clinic in addition to a topical corticosteroid.
1064nm laser
1064nm laser will be used to treat the lesion in this study arm.
Topical corticosteroid
The topical corticosteroid will be used to treat the lesion in this study arm.
Topical corticosteroid alone
Topical corticosteroid is applied to the patient's lesion.
Topical corticosteroid
The topical corticosteroid will be used to treat the lesion in this study arm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
532nm laser
532nm laser will be used to treat the lesion in this study arm.
1064nm laser
1064nm laser will be used to treat the lesion in this study arm.
Topical corticosteroid
The topical corticosteroid will be used to treat the lesion in this study arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to rate level of pain
* Ability to rate visual satisfaction
* At least 2 active lesions of CLE
Exclusion Criteria
* Allergy to triamcinolone or betamethasone dipropionate cream
* Pregnancy
* Currently a prisoner
* Unable to read and speak English since consent will only be available in English
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
David Weinstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Weinstein
Assistant Professor of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCF Health Lake Nona Office
Orlando, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIO-17-13680
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.